Metabolon’s Metabolomics Services Now Cited in More Than 4,000 Peer-Reviewed Publications
Metabolon's best-in-class metabolomics leadership accelerates as metabolomics becomes a standard inclusion in global multiomics studies MORRISVILLE, N.C., Oct. 7, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced that its metabolomics...
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized compound, NDL2, is an advanced PD-L1 protein degrader currently in development and represents a new and innovative frontier of cancer immunotherapy....
Pantai Hospital Kuala Lumpur at Kuala Lumpur Standard Chartered Marathon 2025
From preventive screenings to Medic-On-The-Run, Pantai Hospital Kuala Lumpur brings healthcare beyond the hospital for Generation after Generation. KUALA LUMPUR, Malaysia, Oct. 7, 2025 /PRNewswire/ -- Health, like running, is a journey, not a destination. As Malaysia's runners pushed their limits at the Kuala Lumpur Standard Chartered Marathon (KLSCM) 2025, Pantai Hospital Kuala Lumpur (PHKL) ran with them, not...
Milliken & Company Launches Millad ClearX™ 9000: The Clear Choice for Polypropylene
Delivers exceptional clarity with lower additive levels, streamlining production and expanding formulation options for converters and resin producers SPARTANBURG, S.C., Oct. 7, 2025 /PRNewswire/ -- Milliken & Company proudly announces the launch of Millad ClearX™ 9000, the next generation clarifying technology for polypropylene (PP) developed to deliver ultra-clear transparency at reduced additive loading...
Kadisco General Hospital and MindHYVE.ai™ Sign Strategic MoU to Transform Healthcare in Ethiopia with Agentic AI
ADDIS ABABA, Ethiopia, Oct. 7, 2025 /PRNewswire/ -- Kadisco General Hospital (KGH), one of Ethiopia's leading private healthcare institutions, and MindHYVE.ai™, a U.S.-based pioneer in agentic artificial intelligence (AI), have signed a Memorandum of Understanding (MoU) to launch an ambitious collaboration that will accelerate AI-powered healthcare innovation, operational efficiency, and workforce...
Japanese Innovation Comes to Thailand: Revolutionary Myopia Management Device Kubota Glass Debuts at ASEAN International Optics Fair Bangkok 2025
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Leading Japanese pharmaceutical company Kubota Pharmaceutical Holdings Co., Ltd. will introduce Thailand to its groundbreaking myopia management device, Kubota Glass, at Bangkok. Addressing Thailand's Growing Myopia Crisis Thailand is facing a growing myopia challenge, with studies reporting that over 60%* of young adults are already myopic—among the highest rates observed...
Revolutionary Myopia Management Technology Expands Across Asia — Kubota Glass Makes Global Debut at ASEAN International Optics Fair Bangkok 2025
TOKYO, Oct. 7, 2025 /PRNewswire/ -- Kubota Pharmaceutical Holdings Co., Ltd. (TSE: 4596) today announced that its groundbreaking myopia management device, Kubota Glass, will make its international debut at ASEAN International Optics Fair Bangkok 2025, taking place in Bangkok, Thailand, from October 9-11, 2025. Addressing Asia's Myopia Crisis With half of...
UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer. This study, conducted within the framework of microONE, a pioneering COMET Module programme project...
MPF Powers a Mission-Critical Rebuild of Bridge2Practise: From Legacy Chaos to a Future-Ready Clinical Education Platform
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has partnered with the University of Sydney to deliver a high-stakes, deeply technical modernisation of Bridge2Practise—a clinical skills training platform used by medical students and educators to simulate and assess procedural learning. MPF rebuilds Bridge2Practise, transforming clinical education with modern technology and improved usability ...
NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month
The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along with hereditary risk assessment, featuring seamless integration with additional resources. PLYMOUTH MEETING, Pa., Oct. 6, 2025 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for...
